Clinical evolution and outcomes | Conventional Bacteria vs. Others†† | Conventional Bacteria vs. Atypical Agents†† | ||
---|---|---|---|---|
OR (95% CI) | P value | O7R (95% CI) | P value | |
Clinical evolution | ||||
Treatment failure | 2.3 (0.9–5.8) | 0.1 | 1.5 (0.6–4.2) | 0.4 |
Severe sepsis | 3.0 (1.8–5.1) | <0.0001 | 2.3 (1.2–4.4) | 0.01 |
Septic shock | 15.9 (1.8–142.5) | 0.01 | 11.8 (1.3–109.6) | 0.03 |
Hospitalized | 4.5 (2.7–7.5) | <0.0001 | 5.1 (2.8–9.2) | <0.0001 |
Admission to intensive care unit | 27.9 (3.4–227.9) | 0.002 | 19.5 (2.3–164.1) | 0.006 |
Use of mechanical ventilation | 6.0 (0.5–76.8) | 0.2 | 4.6 (0.3–61.7) | 0.2 |
Outcomes | ||||
Mortality within 30 days | 2.2 (0.4–11.6) | 0.4 | 0.8 (0.1–4.7) | 0.8 |
In-hospital mortality* | 1.1 (0.2–6.3) | 0.9 | 0.3 (0.04–2.4) | 0.3 |
Readmission within 30 days* | 1.4 (0.4–4.9) | 0.6 | 1.7 (0.3–9.2) | 0.5 |
Length of hospital stay*† (days) | ||||
Mean (SD) | 1.2 (1–1.6)║ | 0.05 | 1.2 (0.9–1.7)║ | 0.2 |
>3 | 2.7 (1.3–5.3) | 0.005 | 3.2 (1.2–8.2) | 0.02 |
Return to daily activity†, mean (SD),days | 1.0 (0.9–1.2)║ | 0.6 | 1.1 (0.9–1.3)║ | 0.5 |
Subsequent hospitalization‡ | 0.7 (0.1–6.5) | 0.8 | 0.8 (0.1–8.7) | 0.9 |